The CentriMag™ System is the only acute circulatory support system approved for 30-day LVAD, RVAD and BiVAD support. It offers freedom of choice and fits seamlessly into custom circuit designs, and can be used with a variety of cannulation options.

2011年2月1日 · Although CentriMag VADs are designed and approved only for short-term support, our insertion technique allows longer-term use, when needed, without forced bed rest. Ambulatory rehabilitation has many advantages and prepares the patients for the next stage of the treatment, such as implantable long-term VADs or heart transplantation.

The CentriMag™ Acute Circulatory Support System with Full MagLev™ Flow Technology is designed to offer excellent hemocompatibility and unparalleled versatility for a wide range

Biventricular assist devices (BiVADs) using the CentriMag™ system are being used increasingly as a form of short-term mechanical circulatory support for the treatment of acute cardiogenic shock from any aetiology. They can be used as a bridge to decision, recovery or transplantation.

2024年4月9日 · We describe a safe and reproducible technique of BiVAD implantation using the CentriMag™ system. Our stepwise surgical technique can help other cardiothoracic centres to safely implant BiVAD in these very sick patients to save their lives.

Two nonrandomized, multicenter pilot studies to evaluate the use of the CentriMag System. The first trial used CentriMag as an LVAD or BiVAD to treat patients in cardiogenic shock. The second utilized CentriMag as an RVAD after implantation of a commercially available LVAD.

2017年12月1日 · Objectives: We recently developed a novel minimally invasive surgical approach that combines extracorporeal membrane oxygenation and CentriMag ventricular assist device (Ec-VAD) for the treatment of cardiogenic shock as a short-term circulatory support. We compared the outcomes of this new approach to conventional CentriMag biventricular assist ...

2019年5月15日 · With CentriMag devices, patients can ambulate and stay conditioned in preparation for their orthotopic heart transplant. These devices rely on MagLev technology whereby a free-floating rotor suspended within a constantly adjusted magnetic field delivers blood flow in an environment with minimal shear forces and stasis to reduce cell trauma and ...

They concluded that temporary VAD with CentriMag support is an effective treatment for patients in refractory cardiogenic shock and despite its side effect profile including a high rate of blood transfusion early in the immediate postoperative period of CentriMag support, aggressive use of the CentriMag support device has acceptable survival to ...

2017年1月18日 · The device can provide total circulatory support (acting as a biventricular assist device, or BiVAD) or individual left or right ventricular support (LVAD or RVAD). It can also be used as a part of an extracorporeal membrane oxygenation (ECMO) circuit, but this use is beyond the scope of this briefing.